Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Risk stratification in medulloblastoma: screening for molecular markers].

M Ebinger1, L Senf, W Scheurlen

  • 1Abteilung für Molekulare Pathologie, Institut für Pathologie, Universitätsklinikum Tübingen.

Klinische Padiatrie
|May 12, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Primary immunosuppressive TNI-based conditioning regimens in pediatric patients treated with haploidentical hematopoietic cell transplantation.

Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al]·2021
Same author

Polypharmacy, functional outcome and treatment effect of intravenous alteplase for acute ischaemic stroke.

European journal of neurology·2020
Same author

Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC) - a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14.

Neuropathology and applied neurobiology·2019
Same author

Pediatric Langerhans cell histiocytosis: the impact of mutational profile on clinical progression and late sequelae.

Annals of hematology·2019
Same author

4G versus 3G-enabled telemedicine in prehospital acute stroke care.

International journal of stroke : official journal of the International Stroke Society·2019
Same author

Right insular infarction and mortality after ischaemic stroke.

European journal of neurology·2016

This study investigated molecular markers for medulloblastoma treatment stratification. C-MYC amplification and tumor suppressor gene methylation showed no clear association with patient outcomes, suggesting complex therapeutic strategies are needed.

Area of Science:

  • Molecular Oncology
  • Pediatric Neuro-oncology
  • Cancer Genomics

Context:

  • Medulloblastoma is a common pediatric brain tumor requiring effective therapy stratification.
  • Identifying reliable molecular markers is crucial for predicting treatment response and patient outcomes.
  • Current therapeutic strategies need refinement based on molecular profiling.

Purpose:

  • To evaluate C-MYC amplification as a predictive marker for medulloblastoma.
  • To assess the promoter methylation status of key tumor suppressor genes (CASP8, TIMP3, CDH1, CDKN2A, MGMT) in medulloblastoma.
  • To investigate the expression of GAS7 as a potential molecular marker in medulloblastoma.

Summary:

  • Analysis of 69 medulloblastoma samples revealed no significant association between C-MYC amplification and clinical outcome.

Related Experiment Videos

  • Promoter methylation was non-randomly distributed, with high methylation observed for CASP8; however, no correlation with clinical outcome was found.
  • GAS7 expression was detected in 20/29 tumors, but its role as a tumor suppressor is considered improbable.

    • Impact:

    • Findings suggest C-MYC amplification is not a reliable prognostic marker for medulloblastoma in this cohort.
    • The methylation status of tumor suppressor genes, particularly CASP8, may offer potential therapeutic targets (e.g., via interferon gamma).
    • GAS7 is unlikely to have an antitumorigenic role in medulloblastoma, despite its expression in tumor samples.